Skip to main content

Robert Horvitz Joins GenPath SAB; Prabhavathi Fernandes Named to Supervisory Board of GPC Biotech; Ming Tsuang to Head New UCSD Institute

NEW YORK, May 28 - Robert Horvitz, a Nobel laureate and professor of biology at MIT, has joined the scientific advisory board of GenPath Pharmaceuticals, the company said today.

 

Horvitz won the Nobel Prize in Medicine or Physiology, along with Sydney Brenner and John Sulston, for their work on making C. elegans a model organism and using it in studying apoptosis.  

 

GenPath, of Cambridge, uses genetic model systems for drug discovery in cancer, and uses a high-throughput technology to functionally prioritize drug targets.

 



Prabhavathi Fernandes has been appointed to the supervisory board of GPC Biotech, the Martinsried, Germany, company said May 23.

 

Fernandes has most recently been CEO of Ricera Biosciences. Prior to that, she was a founder and CEO of Small Molecule Therapeutics; and also held the position of vice president, biomolecular screening and drug discovery at Bristol-Myers Squibb Pharmaceutical Research Institute, as well as positions at Abbott Laboratories and the Squibb Institute for Medical Research.

  
The company also reelected other existing members of its supervisory board, including the chairman, J rgen Drews; Helmut M. Sch hsler, Metin Colpan, Michael Lytton, and Peter Preuss.  


 

Ming Tsuang has been named director of the Universityof California San Diego's new Instituteof Behavioral Genomics, the university said May 21.

 

Tsuang is a professor of psychiatry at the HarvardMedicalSchooland is director of the Harvard Institute of Psychiatric Epidemiology and Genetics and the Harvard Department of Psychiatry at the MassachusettsMentalHealthCenter.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.